GNH USA

USA — NDC

Creon 19000 [USP'U]/1

Creon 19000 [USP'U]/1 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-r

Pancrelipase
Creon
CAPSULE, DELAYED RELEASE PELLETS
19000 [USP'U]/1

Request sourcing

1
Pack/s

What is Pancrelipase?

Creon 19000 [USP'U]/1 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-release capsule helps break down fats, proteins, and carbohydrates, supporting nutrient absorption. Ideal for managing digestive health, Creon 19000 [USP'U]/1 is a trusted solution for those needing digestive enzyme support.

What is Pancrelipase used for?

Creon 19000 [USP'U]/1 is primarily used to treat exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. This medication helps the body digest fats, proteins, and carbohydrates more effectively, which can alleviate symptoms such as bloating, diarrhea, and fatty stools. It is often prescribed for individuals with chronic pancreatitis, cystic fibrosis, or those who have undergone pancreatic surgery. The primary keyword here is 'pancreatic enzyme replacement therapy', and related searches might include 'what is Creon 19000 [USP'U]/1 used for' or 'digestive enzyme support'.

What are the side effects of Pancrelipase?

Common effects of Creon 19000 [USP'U]/1 may include improved digestion and reduced symptoms like bloating, gas, and diarrhea. Some users might experience mild stomach discomfort or changes in bowel movements. It's important to note that individual responses can vary, and not everyone will experience the same effects. Always consult a healthcare provider for personalized advice.

What precautions apply to Pancrelipase?

Creon 19000 [USP'U]/1 should be handled with care, especially ensuring it is stored properly to maintain its effectiveness. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid crushing or chewing the capsules, as this can affect their delayed-release mechanism. Additionally, individuals with certain allergies or pre-existing conditions should inform their healthcare provider before starting this medication.

What does Pancrelipase interact with?

Creon 19000 [USP'U]/1 may interact with other medications, particularly those that affect digestion or nutrient absorption. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods or supplements might influence the effectiveness of this medication. Always consult a healthcare professional for personalized advice regarding interactions.

Frequently asked questions

What is Creon 19000 [USP'U]/1 used for?+
Creon 19000 [USP'U]/1 is used to treat exocrine pancreatic insufficiency, helping the body digest fats, proteins, and carbohydrates more effectively.
How should I take Creon 19000 [USP'U]/1?+
Creon 19000 [USP'U]/1 should be taken orally with meals or snacks, following the dosage instructions provided by your healthcare provider.
What are the common side effects of Creon 19000 [USP'U]/1?+
Common side effects may include mild stomach discomfort, bloating, gas, or changes in bowel movements.
Can I crush or chew Creon 19000 [USP'U]/1 capsules?+
No, Creon 19000 [USP'U]/1 capsules should not be crushed or chewed, as this can affect their delayed-release mechanism.
Who should not take Creon 19000 [USP'U]/1?+
Individuals with certain allergies or pre-existing conditions should consult a healthcare provider before taking Creon 19000 [USP'U]/1.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pancrelipase
Brand
Creon
Strength
19000 [USP'U]/1
Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Pack size
1 BOTTLE in 1 CARTON (0032-1206-01) / 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE
Manufacturer
AbbVie Inc.
Origin
USA

Related products